A Case of Perioral Dermatitis Successfully Treated with Abrocitinib

被引：4

作者：

Teng, Yan ^{[1
]}

Ren, Mingyang ^{[2
]}

Ding, Yang ^{[1
]}

Yang, Xianhong ^{[1
]}

Fan, Yibin ^{[1
,3
]}

Tao, Xiaohua ^{[1
,3
]}

机构：

[1] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Ctr Plast & Reconstruct Surg, Dept Dermatol,Affiliated Peoples Hosp, Hangzhou 310014, Peoples R China

[2] Bengbu Med Sch, Grad Sch Clin Med, Bengbu, Peoples R China

[3] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Ctr Plast & Reconstruct Surg, Peoples Hosp,Dept Dermatol, Hangzhou, Peoples R China

来源：

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY | 2023年 / 16卷

关键词：

JAK inhibitors; abrocitinib; perioral dermatitis;

D O I：

10.2147/CCID.S433561

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Perioral dermatitis (POD) is a chronic inflammatory skin disease that primarily affects females between the ages of 16 and 45. Conventional therapies face the challenge of limited efficacy and a high recurrence rate. In this report, we present the case of a 26 -year-old male patient with POD who was successfully treated using the Janus kinase (JAK) inhibitor, abrocitinib. This treatment exhibited both good efficacy and safety. Abrocitinib, as a JAK inhibitor, holds promise as a potential therapy for cases of POD that might be resistant to conventional therapies.

引用

页码：3035 / 3038

页数：4

共 10 条

[1] Effect of abrocitinib in a patient with extensive necrobiosis lipoidica [J].

Arnet, L. ;

Erfurt-Berge, C. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) :E1208-E1210

[2] Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases [J].

Bai, Juan ;

Su, Wang ;

Fang, Hong ;

Qiao, Jianjun .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (09) :E480-E483

[3] Abrocitinib as a novel treatment for lichen sclerosus [J].

Bao, Chengbei ;

Xu, Qiuyun ;

Xiao, Zhixun ;

Wang, Haiqing ;

Luo, Renwei ;

Cheng, Bo ;

Ji, Chao ;

Gong, Ting .

BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (01) :136-138

[4] Successful treatment of chronic severe alopecia areata with abrocitinib [J].

Bennett, Michaela ;

Moussa, Anthony ;

Sinclair, Rodney .

AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (02) :274-276

[5] Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial [J].

Blauvelt, Andrew ;

Silverberg, Jonathan, I ;

Lynde, Charles W. ;

Bieber, Thomas ;

Eisman, Samantha ;

Zdybski, Jacek ;

Gubelin, Walter ;

Simpson, Eric L. ;

Valenzuela, Fernando ;

Criado, Paulo Ricardo ;

Lebwohl, Mark G. ;

Feeney, Claire ;

Khan, Tahira ;

Biswas, Pinaki ;

DiBonaventura, Marco ;

Valdez, Hernan ;

Cameron, Michael C. ;

Rojo, Ricardo .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) :104-112

[6] Improvement of Hailey-Hailey disease with abrocitinib [J].

Li, Yufen ;

Jiang, Yiqun ;

Sun, Jianfang .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (05) :532-533

[7] Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases [J].

Noguera-Morel, Lucero ;

Gerlero, Paula ;

Torrelo, Antonio ;

Hernandez-Martin, Angela .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (03) :567-570

[8] Perioral dermatitis: Diagnosis, proposed etiologies, and management [J].

Searle, Tamara ;

Ali, Faisal R. ;

Al-Niaimi, Firas .

JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (12) :3839-3848

[9] Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib [J].

Vander Does, Ashley ;

Yosipovitch, Gil .

DERMATITIS, 2023, 34 (06) :567-567

[10] The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis - A network meta-analysis [J].

Zhang, L. ;

Guo, L. ;

Wang, L. ;

Jiang, X. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) :1937-1946

← 1 →